Findlay Copley-Bewicke

Charterhouse Sq
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Journal: iScience

Published: June 13, 2025

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Journal: Leukemia

Published: October 15, 2024

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

Journal: British journal of haematology

Published: April 22, 2024

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.

Journal: Leukemia

Published: December 22, 2023

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.

Journal: Blood cancer journal

Published: September 16, 2023

Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers.

Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers.

Journal: The Journal of molecular diagnostics : JMD

Published: June 23, 2023

Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.

Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.

Journal: Journal of the American Academy of Dermatology

Published: April 21, 2023

CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.

CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.

Journal: Science translational medicine

Published: June 22, 2022

Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.

Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.

Journal: British journal of haematology

Published: June 17, 2022

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.

Journal: Signal transduction and targeted therapy

Published: May 20, 2022

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Journal: Blood advances

Published: March 18, 2022

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.

Journal: Nature communications

Published: December 01, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026